Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dose Optimization of H56:IC31 Vaccine for Tuberculosis-Endemic Populations. A Double-Blind, Placebo-controlled, Dose-Selection Trial
Sara Suliman, Angelique Kany Kany Luabeya, Hennie Geldenhuys, et al.
American Journal of Respiratory and Critical Care Medicine (2018) Vol. 199, Iss. 2, pp. 220-231
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

In silico analysis of epitope-based vaccine candidate against tuberculosis using reverse vaccinology
Shaheen Bibi, Inayat Ullah, Bingdong Zhu, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 157
Next-Generation TB Vaccines: Progress, Challenges, and Prospects
Zhuang Li, Zhaoyang Ye, Linsheng Li, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1304-1304
Open Access | Times Cited: 58
Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
Zhuang Li, Ling Yang, Linsheng Li, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 20
The role of ESAT-6 in tuberculosis immunopathology
Beatriz B. S. Passos, Mariana Araújo‐Pereira, Caian L. Vinhaes, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
A Modular Self‐Assembling and Self‐Adjuvanting Multiepitope Peptide Nanoparticle Vaccine Platform to Improve the Efficacy and Immunogenicity of BCG
Guangzu Zhao, Harindra D. Sathkumara, Socorro Miranda‐Hernandez, et al.
Small (2025)
Open Access | Times Cited: 2
Moving tuberculosis vaccines from theory to practice
Peter Andersen, Thomas J. Scriba
Nature reviews. Immunology (2019) Vol. 19, Iss. 9, pp. 550-562
Open Access | Times Cited: 136
Targeting innate immunity for tuberculosis vaccination
Shabaana A. Khader, Maziar Divangahi, Willem A. Hanekom, et al.
Journal of Clinical Investigation (2019) Vol. 129, Iss. 9, pp. 3482-3491
Open Access | Times Cited: 117
Tuberculosis Vaccine Development: Progress in Clinical Evaluation
Suraj B. Sable, James E. Posey, Thomas J. Scriba
Clinical Microbiology Reviews (2019) Vol. 33, Iss. 1
Open Access | Times Cited: 94
Key recent advances in TB vaccine development and understanding of protective immune responses against Mycobacterium tuberculosis
Thomas J. Scriba, Mihai G. Netea, Ann M. Ginsberg
Seminars in Immunology (2020) Vol. 50, pp. 101431-101431
Open Access | Times Cited: 82
A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates
Miguel Rodo, Virginie Rozot, Elisa Nemes, et al.
PLoS Pathogens (2019) Vol. 15, Iss. 3, pp. e1007643-e1007643
Open Access | Times Cited: 79
Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
Stefan H. E. Kaufmann
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 75
Clinical Development of New TB Vaccines: Recent Advances and Next Steps
Mark Hatherill, Richard G. White, Thomas R. Hawn
Frontiers in Microbiology (2020) Vol. 10
Open Access | Times Cited: 73
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Therapeutic Vaccines for Tuberculosis: An Overview
Rania Bouzeyen, Babak Javid
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 49
Adjuvant physiochemistry and advanced nanotechnology for vaccine development
Hongze Ren, Wencong Jia, Yujie Xie, et al.
Chemical Society Reviews (2023) Vol. 52, Iss. 15, pp. 5172-5254
Closed Access | Times Cited: 37
Tuberculosis vaccine development: from classic to clinical candidates
Junli Li, Aihua Zhao, Jun Tang, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2020) Vol. 39, Iss. 8, pp. 1405-1425
Open Access | Times Cited: 55
Chronic Immune Activation in TB/HIV Co-infection
Riti Sharan, Allison N. Bucşan, Shashank Ganatra, et al.
Trends in Microbiology (2020) Vol. 28, Iss. 8, pp. 619-632
Open Access | Times Cited: 54
A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
Synne Jenum, Kristian Tonby, Corina S. Rueegg, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 48
It Takes a Village: The Multifaceted Immune Response to Mycobacterium tuberculosis Infection and Vaccine-Induced Immunity
Sasha E. Larsen, Brittany D. Williams, Maham Rais, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 34
Advances in protein subunit vaccines against tuberculosis
Ying Zhang, Jinchuan Xu, Zhidong Hu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates
Fangbin Zhou, Dongmei Zhang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 19
Gene Regulatory Mechanism of Mycobacterium Tuberculosis during Dormancy
Yiduo Liu, Han Li, Dejia Dai, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 6, pp. 5825-5844
Open Access | Times Cited: 8
Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis
Guneswar Sethi, Rinku Polachirakkal Varghese, Avinash Kant Lakra, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Infect and Inject: How Mycobacterium tuberculosis Exploits Its Major Virulence-Associated Type VII Secretion System, ESX-1
Sangeeta Tiwari, Rosalyn Casey, Celia W. Goulding, et al.
Microbiology Spectrum (2019) Vol. 7, Iss. 3
Open Access | Times Cited: 45
Expanding the role of bacterial vaccines into life-course vaccination strategies and prevention of antimicrobial-resistant infections
Jan Poolman
npj Vaccines (2020) Vol. 5, Iss. 1
Open Access | Times Cited: 44
Page 1 - Next Page

Scroll to top